GRIFFINI, SAMANTHA

GRIFFINI, SAMANTHA  

DIPARTIMENTO DI MEDICINA INTERNA (attivo dal 01/01/1998 al 27/04/2012)  

Mostra records
Risultati 1 - 20 di 30 (tempo di esecuzione: 0.004 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Activation of inflammation, coagulation and fibrinolysis in patients with Rheumatoid Arthritis : inhibition by Tumor Necrosis Factor alpha blockade 1-gen-2008 F.A. IngegnoliF. FantiniE. G. FavalliV. GalbiatiA. SoldiS. GriffiniM. Cugno + Article (author) -
Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria 1-mar-2007 S. GriffiniP. RiboldiA.V. MarzanoD. FanoniM. Cugno + Article (author) -
Anti-t-PA antibodies in acute myocardial infarction after thrombolysis with rt-PA 1-feb-2010 M. CugnoR. CastelliS. GriffiniP. L. Meroni + Article (author) -
Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis 1-gen-2010 F. A. IngegnoliF. FantiniS. GriffiniA. SoldiP. MeroniM. Cugno Article (author) -
Antibodies to tissue-type plasminogen activator in patients with inflammatory bowel disease 1-gen-2006 M. CugnoS. SaibeniS. GriffiniR. de FranchisM. Vecchi + Article (author) -
Assessment of Anti-Tissue Type Plasminogen Activator Antibodies in Patients With Prosthetic Heart Valve Thrombosis: The ATA Trial 8-dic-2016 S. GriffiniM. Cugno + Article (author) -
Chronic urticaria patients show signs of thrombin generation and are much more frequently positive on autologous plasma skin test than on autologous serum skin test 1-giu-2006 P. RiboldiS. GriffiniM. Cugno + Conference Object -
Coagulation cascade and fibrinolysis in patients with multiple-drug allergy syndrome 1-gen-2008 P. RiboldiS. GriffiniM. Cugno + Article (author) -
Complement activation in patients with COVID-19: a novel therapeutic target 1-gen-2020 Cugno, MassimoMeroni, Pier LuigiGualtierotti, RobertaGriffini, SamanthaAliberti, StefanoBlasi, FrancescoPeyvandi, Flora + Article (author) -
Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome: an update 1-mar-2018 F. TelGIUSSANI, ANTENORES. GriffiniF. PaglialongaP. MessaM. Cugno + Article (author) -
Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination 1-nov-2021 Cugno M.Griffini S.Valenti L.Bonato S.Comi G.Artoni A.Meroni P. L.Peyvandi F. + Article (author) -
Early endothelial damage in patients with raynaud's phenomenon 1-gen-2017 R. GualtierottiF. IngegnoliT. SchioppoS. GriffiniM. BorghiM. Cugno + Article (author) -
Eculizumab treatment in atypical hemolytic uremic syndrome: correlation between functional complement tests and drug levels 1-gen-2022 Cugno, MassimoCapone, ValentinaGriffini, SamanthaPintarelli, GiuliaClementi, Emilio + Article (author) -
Effect of tumor necrosis factor alpha blockade on inflammatory and haemostatic biomarkers in patients with rheumatoid arthritis 1-gen-2007 F. IngegnoliM. CugnoE. FavalliA. SoldiS. GriffiniV. GalbiatiF. Fantini + Article (author) -
Effetto della terapia con infliximab sui marcatori di infiammazione, coagulazione e fibrinolisi nell’artrite reumatoide 1-gen-2008 F. IngegnoliM. CugnoV. GalbiatiA. SoldiE. G. FavalliS. GriffiniP.L. MeroniF. Fantini Article (author) -
Haemostatic and inflammatory biomarkers in patients with active Rheumatoid Arthritis : effects of Tumor Necrosis Factor alpha blockade 1-gen-2008 F. IngegnoliF. FantiniV. GalbiatiA. SoldiR. GualtierottiS. GriffiniE. G. FavalliM. Cugno Article (author) -
Haemostatic and inflammatory biomarkers in patients with rheumatoid arthritis : effect of tumor necrosis factor alpha blockade 1-gen-2007 M. CugnoF. IngegnoliE. FavalliSOLDI, AMEDEOS. GriffiniV. GalbiatiF. Fantini + Article (author) -
IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome 3-mag-2021 Cugno, MassimoBerra, SilviaDepetri, FedericaGriffini, SamanthaCaccia, SoniaMessa, PiergiorgioPeyvandi, Flora + Article (author) -
Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis : effects of tumor necrosis factor-alpha blockade 1-gen-2008 F. IngegnoliF. FantiniE. G. FavalliA. SoldiS. GriffiniV. GalbiatiP. MeroniM. Cugno Article (author) -
Kidney transplant in patients with atypical hemolytic uremic syndrome in the anti-C5 era: single-center experience with tailored Eculizumab 6-mag-2021 Ardissino G.Tel F.Salardi S.Strumbo B.Capone V.Griffini S.Cugno M.Messa P. + Article (author) -